- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05337930
Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine
'Happyr Tracking': Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine
This study aims to inform the continued development of a mobile app intended to support the treatment of CYP with migraine. After extensive public and patient involvement, Happyr Health has developed a mobile app that allows children and young people to track headache attacks and emotional wellbeing and to access coping techniques. With the use of gamification and storytelling elements, the app aims to engage children to be an active part in tracking and coping with their headaches. The outcomes of this study will inform future adaptations and development cycles of the Happyr Health app.
15 participants aged 10-16 will access the Happyr app for 8 weeks (= intervention). Primary outcomes of acceptability and implementation will be measured via surveys following the 8-week intervention in the app.
Study Overview
Detailed Description
The Happyr App is a mobile app to support children and young people with primary headaches in tracking their mood and symptoms. The app was developed in close collaboration with patients, their parents, and clinicians (pediatric neurologists, pediatric pain psychologists).
In the 'Happyr Tracking' study, we recruit 15 CYP aged 10-16 from the neurology department at Leeds Teaching Hospitals NHS Trust. Participants experience at least three primary headache attacks per month.
After receiving information on the study via the Principal Investigator (PI), those interested can contact the research team to receive access to the Happyr App.
In the app, participants and their parents/legal caregivers review information on the study and give their assent/consent. A copy of their signed assent/consent document will be sent to them as well as the research team and sponsor via email.
After creating their account, participants receive a survey in the app. As soon as completed, they can access the app's features. Participants are asked to make an entry to their mood diary at least once per day and to their pain diary only on days they experienced a pain attack. Participants are asked to send a PDF of their pain diary data (which they can export in the app) to the PI at the end of the intervention period (8 weeks).
After 8 weeks of using the app, participants will automatically receive another survey in the app to complete their participation. The pain diary export can be discussed with their clinician at their next appointment.
Outcomes of the study will be analyzed from the two in-app survey at beginning and end of the intervention period as well as usage data from the app analytics. The study objective is to understand the acceptability and feasibility of the Happyr App.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nicola Filzmoser
- Phone Number: +447426451565
- Email: nicola@happyrhealth.com
Study Locations
-
-
-
Leeds, United Kingdom
- The Leeds Teaching Hospitals NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- With recurrent headaches (at least 3x per month)
- Access to a device (Android or iOS smartphone)
- Access to internet connection
- English-speaking
Exclusion Criteria:
- Secondary headaches
- Continuous headache
- Severe cognitive impairments
- Major comorbid medical or psychiatric illnesses (e.g. severe anxiety disorder)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention arm
Study participants will use the Happyr Health app, a mobile application to support CYP with primary headaches in coping with chronic pain, for eight weeks.
For this study, a research version of the app will be provided via Google Play Store Testing Tracks and Apple TestFlight.
In the app, a storyline and gamification elements engage CYP in filling out their headache diary and a regular mood diary.
|
The Happyr app offers three main areas: (A) A mood diary in which a user can keep track of emotional wellbeing by answering three short questions. (B) A pain diary in which a user and supporter can record headache attacks by answering a set of predefined questions whenever a user experiences or has experienced a headache attack. (C) An overview section in which entries from the mood and pain diary are visualized for the user. In this section, a PDF document can also be exported with a summary of data from the symptom diary that can be taken to the clinician. A standardized notification is sent to each user at 6pm local time to remind them about logging their mood and symptoms of a headache attack. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability Modified 'The mHealth App Usability Questionnaire (MAUQ)'
Time Frame: Post 8-week intervention
|
Acceptability of the app to patients will be measured using items adapted from the mHealth App Usability Questionnaire.
Questions use a Likert agreement response scale.
A higher total score reflects greater acceptability (1 = strongly disagree (worse outcome); 5 = strongly agree (better outcome)).
Our selected threshold for defining adequate acceptability is that 80% of participants will have an average score of at least 4/5 on the acceptability questionnaire (indicating moderate to high satisfaction with the app).
Participants also will be asked in an open-ended item to provide general comments about their experience with the app.
|
Post 8-week intervention
|
Implementation (App usage frequency)
Time Frame: Post 8-week intervention
|
Implementation will be evaluated using app analytics to measure the frequency of making a mood diary entry per week.
Our selected threshold for defining acceptable implementation is that 80% of participants will submit an average of at least 4 completed daily diaries per week over the course of 8 weeks.
|
Post 8-week intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Munni Ray, The Leeds Teaching Hospitals NHS Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 308617
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Headache Disorder
-
VR1 CorporationTerminatedPrimary Headache DisordersUnited States
-
Tartu University HospitalUniversity of TartuRecruitingMigraine | Primary Headache DisordersEstonia
-
Ankara City Hospital BilkentActive, not recruitingPrimary Headache DisorderTurkey
-
Aksaray University Training and Research HospitalCompleted
-
Stanford UniversityCompletedHeadache DisordersUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownPrimary Headache DisorderFrance
-
Antonio Francesco UrbinoScuola Superiore di Osteopatia ItalianaUnknownHeadache Disorders | Primary Headache DisorderItaly
-
Montefiore Medical CenterCompletedMigraine | Tension-type Headache | Primary Headache DisorderUnited States
-
University of AarhusDanish Headache Center; Aarhus University HospitalActive, not recruitingPain | Headache | Cluster Headache | Chronic Cluster Headache | Primary Headache Disorder | Trigeminal Autonomic Cephalgia | CephalgiaDenmark
-
Danish Headache CenterUnknownMigraine Without Aura | Chronic Tension-Type HeadacheDenmark
Clinical Trials on Happyr App
-
University of VictoriaRecruiting
-
Hypnalgesics, LLCTufts UniversityCompletedDental Anxiety | Opioid Use | Drug Use | Dental PainUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedCancer | Financial Toxicity | Question Prompt ListUnited States
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
The University of Hong KongNot yet recruitingDigital Health | Knee Pain/OsteoarthritisHong Kong
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityActive, not recruiting
-
University Hospitals Cleveland Medical CenterNot yet recruiting
-
Singapore Institute for Clinical SciencesRecruitingType 2 Diabetes | Gestational Diabetes | Healthy Lifestyle BehaviorsSingapore
-
University of Sao PauloNot yet recruitingPostpartum Depression